Olfr509 Inhibitors
Olfr509, a member of the olfactory receptor family, plays a pivotal role in the complex process of olfactory perception. Positioned within the nasal epithelium, Olfr509 interacts with odorant molecules to initiate a neuronal response, ultimately giving rise to the perception of distinct smells. Characterized by a 7-transmembrane domain structure typical of G-protein-coupled receptors (GPCRs), Olfr509 shares fundamental features with neurotransmitter and hormone receptors. The gene encoding Olfr509 is a single coding-exon gene, contributing to the expansive olfactory receptor gene family, which stands as the largest in the genome. The nomenclature assigned to Olfr509 emphasizes its unique identity within this family, independent of other organisms.
Olfr509 functions as a GPCR responsible for the recognition and G protein-mediated transduction of odorant signals. The intricate process begins with the binding of odorant molecules to Olfr509, inducing conformational changes that activate downstream signaling pathways. These pathways, shared with neurotransmitter and hormone receptors, contribute to the transduction of odorant signals, ultimately leading to the perception of smells. Olfr509's role in this complex cascade highlights its significance in shaping the diversity and sensitivity of the olfactory sense. Inhibition of Olfr509 involves a sophisticated approach, encompassing both direct and indirect mechanisms. Direct inhibitors may perturb the structural conformation of Olfr509, impeding its effective binding to odorant molecules. In contrast, indirect inhibitors modulate specific signaling pathways associated with Olfr509, disrupting the transduction of odorant signals. For instance, chemicals targeting ion transport, dopaminergic signaling, sterol biosynthesis, and various other pathways can indirectly influence Olfr509 function. The resultant disruption alters the GPCR-mediated transduction of odorant signals, impacting the neuronal response and, consequently, the perception of smells. Understanding these nuanced mechanisms provides valuable insights into the intricate regulation of olfactory perception, offering avenues for scientific exploration of this sensory process.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Niflumic Acid, a chloride channel blocker, indirectly inhibits Olfr509 by modulating ion transport pathways. This disruption influences GPCR-mediated transduction of odorant signals, leading to altered neuronal response and perception of smells. | ||||||
Aripiprazole | 129722-12-9 | sc-207300 sc-207300A sc-207300B | 100 mg 1 g 5 g | $179.00 $212.00 $1037.00 | 3 | |
Aripiprazole, a dopamine receptor modulator, indirectly inhibits Olfr509 by influencing dopaminergic signaling pathways. This alteration disrupts GPCR-mediated transduction of odorant signals, affecting the neuronal response and perception of smells. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $78.00 $142.00 | 23 | |
Itraconazole, a fungal CYP51 inhibitor, indirectly inhibits Olfr509 by affecting sterol biosynthesis. This alteration influences GPCR-mediated transduction of odorant signals, disrupting the neuronal response and perception of smells. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
Furosemide, a loop diuretic, indirectly inhibits Olfr509 by modulating ion transport pathways. This disruption influences GPCR-mediated transduction of odorant signals, leading to altered neuronal response and perception of smells. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone, a PPARγ agonist, indirectly inhibits Olfr509 by influencing peroxisome proliferator-activated receptor signaling pathways. This alteration disrupts GPCR-mediated transduction of odorant signals, impacting the neuronal response and perception of smells. | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | $62.00 $86.00 | 1 | |
Cimetidine, an H2 receptor antagonist, indirectly inhibits Olfr509 by modulating histaminergic signaling pathways. This disruption influences GPCR-mediated transduction of odorant signals, leading to altered neuronal response and perception of smells. | ||||||
Pentoxifylline | 6493-05-6 | sc-203184 | 1 g | $20.00 | 3 | |
Pentoxifylline, a phosphodiesterase inhibitor, indirectly inhibits Olfr509 by affecting cyclic nucleotide signaling pathways. This alteration disrupts GPCR-mediated transduction of odorant signals, impacting the neuronal response and perception of smells. | ||||||
Ritonavir | 155213-67-5 | sc-208310 | 10 mg | $124.00 | 7 | |
Ritonavir, a protease inhibitor, indirectly inhibits Olfr509 by modulating intracellular signaling pathways. This disruption influences GPCR-mediated transduction of odorant signals, leading to altered neuronal response and perception of smells. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole, an antifungal agent, indirectly inhibits Olfr509 by affecting sterol biosynthesis. This alteration influences GPCR-mediated transduction of odorant signals, disrupting the neuronal response and perception of smells. | ||||||
Ciprofloxacin | 85721-33-1 | sc-217900 | 1 g | $43.00 | 8 | |
Ciprofloxacin, a fluoroquinolone antibiotic, indirectly inhibits Olfr509 by affecting DNA gyrase activity. This alteration influences GPCR-mediated transduction of odorant signals, disrupting the neuronal response and perception of smells. | ||||||